Deep learning algorithms for timely diagnosis of retinopathy of prematurity requiring treatment

Nasser Shoeibi1, Nafise Ameri2, Mohammad Reza Hoseinkhani3

  • 1Eye Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

Eye (London, England)
|November 3, 2025
PubMed

Insights

Deep learning (DL) algorithms show promise for diagnosing Retinopathy of Prematurity (ROP). MobileNet with CLAHE preprocessing achieved high accuracy and sensitivity for ROP detection in telemedicine screenings.

Area of Science:

  • Ophthalmology
  • Medical Imaging
  • Artificial Intelligence

Background:

  • Retinopathy of Prematurity (ROP) is a leading cause of vision impairment in preterm infants.
  • Early diagnosis and treatment are crucial to prevent severe visual outcomes.
  • Telemedicine systems offer a potential solution for ROP screening in remote or underserved areas.

Purpose of the Study:

  • To evaluate the effectiveness of deep learning (DL) algorithms for diagnosing treatment-requiring Retinopathy of Prematurity (ROP).
  • To assess the performance of various convolutional neural network (CNN) models using fundus images from a telemedicine consultation system.

Main Methods:

  • A retrospective cross-sectional study analyzed 1700 RetCam fundus images from 141 preterm infants.
  • Image preprocessing techniques included Contrast Limited Adaptive Histogram Equalisation (CLAHE) and Automated Multiscale Retinex (AMSR).
  • Evaluated CNN models: MobileNet, ResNet-18, ResNet-50, and DenseNet-121, using accuracy, sensitivity, specificity, and F1-score.

Main Results:

  • MobileNet with CLAHE preprocessing achieved the highest accuracy (91.39%) and sensitivity (94.90%) for ROP detection.
  • DenseNet-121 with CLAHE showed high sensitivity (94.26%) and accuracy (90.98%).
  • ResNet-50 with AMSR demonstrated strong performance with 90.58% accuracy and 91.44% sensitivity.

Conclusions:

  • Deep learning models, particularly MobileNet with CLAHE, are effective for diagnosing treatment-requiring ROP.
  • These findings support the feasibility of AI-assisted ROP screening in telemedicine settings.
  • Further validation in diverse clinical environments is recommended to confirm real-world applicability.
Abstract